An examination of the activity of expired and mistreated commercial Australian antivenoms

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 103, Issue 9, 2009, Pages 937-942

  O'Leary, Margaret A ^a   Kornhauser, Rachelle S ^b   Hodgson, Wayne C ^b   Isbister, Geoffrey K ^a,b,c  

^a CALVARY MATER NEWCASTLE HOSPITAL   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

Author keywords

Antibodies; Antivenom; Coagulopathy; Neurotoxicity; Snake; Snake bite

Indexed keywords

SNAKE VENOM ANTISERUM;

ANIMAL TISSUE; ARTICLE; AUSTRALIA; BINDING AFFINITY; BLOOD CLOTTING DISORDER; BLOOD CLOTTING TEST; CONTROLLED STUDY; DRUG ACTIVITY; ENVENOMATION; ENZYME IMMUNOASSAY; FREEZE THAWING; IN VITRO STUDY; NEUROTOXICITY; NONHUMAN; OPTICAL DENSITY; SHELF LIFE;

ANIMALS; ANTIVENINS; AUSTRALASIA; BLOOD COAGULATION; CHICKENS; DRUG STABILITY; IMMUNOENZYME TECHNIQUES; NEUROMUSCULAR JUNCTION; SNAKE BITES; SNAKE VENOMS;

STORERIA DEKAYI;

EID: 68249121374     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trstmh.2008.11.011     Document Type: Article

References (13)

1. O'Leary M.A., Isbister G.K., Schneider J.J., Brown S.G., and Currie B.J. Enzyme immunoassays in brown snake (Pseudonaja spp.) envenoming: detecting venom, antivenom and venom-antivenom complexes. Toxicon 48 (2006) 4-11
2. He S., Antovic A., and Blomback M. A simple and rapid laboratory method for determination of haemostasis potential in plasma. II. Modifications for use in routine laboratories and research work. Thromb Res 103 (2001) 355-361
3. WHO. Progress in the characterization of venoms and standardization of antivenoms. Geneva: World Health Organization; 1981. WHO Offset Publication No. 58.
4. Crachi M.T., Hammer L.W., and Hodgson W.C. The effects of antivenom on the in vitro neurotoxicity of venoms from the taipans Oxyuranus scutellatus, Oxyuranus microlepidotus and Oxyuranus scutellatus canni. Toxicon 37 (1999) 1771-1778
5. Kuruppu S., Reeve S., Banerjee Y., Kini R.M., Smith A.I., and Hodgson W.C. Isolation and pharmacological characterization of cannitoxin, a presynaptic neurotoxin from the venom of the Papuan taipan (Oxyuranus scutellatus canni). J Pharmacol Exp Ther 315 (2005) 1196-1202
6. Clarke C., Kuruppu S., Reeve S., Ian S.A., and Hodgson W.C. Oxylepitoxin-1, a reversible neurotoxin from the venom of the inland taipan (Oxyuranus microlepidotus). Peptides 27 (2006) 2655-2660
7. Isbister G.K., Brown S.G.A., and Duffull S.B. Failure of antivenom in venom induced consumption coagulopathy: in silica and empirical evidence [abstract]. Clin Toxicol 46 (2008) 1
8. Lalloo D.G., Trevett A.J., Korinhona A., Nwokolo N., Laurenson I.F., Paul M., et al. Snake bites by the Papuan taipan (Oxyuranus scutellatus canni): paralysis, hemostatic and electrocardiographic abnormalities, and effects of antivenom. Am J Trop Med Hyg 52 (1995) 525-531
9. Isbister G.K., O'Leary M.A., Schneider J.J., Brown S.G., and Currie B.J. Efficacy of antivenom against the procoagulant effect of Australian brown snake (Pseudonaja sp.) venom: in vivo and in vitro studies. Toxicon 49 (2007) 57-67
10. Kuruppu S., Smith A.I., Isbister G.K., and Hodgson W.C. Neurotoxins from Australo-Papuan elapids: a biochemical and pharmacological perspective. Crit Rev Toxicol 38 (2008) 73-86
11. ® Africa) against African vipers and elapids. Toxicon 52 (2008) 881-888
12. Laing G.D., Yarleque A., Marcelo A., Rodriguez E., Warrell D.A., and Theakston R.D. Preclinical testing of three South American antivenoms against the venoms of five medically-important Peruvian snake venoms. Toxicon 44 (2004) 103-106
13. Barfaraz A., and Harvey A.L. The use of the chick biventer cervicis preparation to assess the protective activity of six international reference antivenoms on the neuromuscular effects of snake venoms in vitro. Toxicon 32 (1994) 267-272